Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods for independent analysis of multiple biological processes in encapsulated 3D cell co-cultures

A biological process and co-cultivation technology, applied in the direction of supporting/immobilizing microorganisms, biochemical equipment and methods, biomaterial analysis, etc., can solve the problems of distinguishing various cysts, not disclosing any means, and not being easy to microscope

Pending Publication Date: 2022-05-13
UNIVERSITY OF GENEVA
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

While these articles are similar to current technology in that different fluorescent dyes (quantum dots) can be used to label cysts, none of them disclose any means of detecting multiple biological processes per test, nor can they be easily differentiated microscopically Various cysts, since liposomes are mainly used for genetic diagnosis of tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for independent analysis of multiple biological processes in encapsulated 3D cell co-cultures
  • Methods for independent analysis of multiple biological processes in encapsulated 3D cell co-cultures
  • Methods for independent analysis of multiple biological processes in encapsulated 3D cell co-cultures

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0080] According to another embodiment of the present invention, said at least one or more cell types are selected from the group comprising cell lines or primary tissue cell subpopulations: hepatocytes, tumor cells, brain cells, epithelial cells, endothelial cells , immune system cells, pluripotent stem cells, embryonic stem cells, lung cells, kidney cells, arterial cells, bone cells, chondrocytes, muscle cells, pancreatic cells, intestinal cells, skin cells, fibroblasts, fungal cells or bacteria.

[0081] Preferably, at least one of said one or more cell types to be analyzed in the in vitro drug testing assay or at least one of the optionally added unlabeled cell types of step c) is a hepatocyte .

[0082] According to one embodiment of the invention, at least one of said one or more types of encapsulated cells is derived from a patient cancer sample.

[0083] According to one embodiment of the invention, at least one of said one or more cell types is a bacterial or fungal ...

Embodiment 1

[0127] describe:

[0128] Monolayers of breast cancer (BC) cells (MELN cells, Tables 1 and 2) stably expressing a luciferase reporter gene under the control of estrogen-responsive elements were co-cultured with or without encapsulated liver cancer (LC) cells and treated with Treatment with increasing concentrations of tamoxifen or 4-hydroxy tamoxifen for 48 hours. The activity of estrogen receptor alpha in BC cells was determined by measuring the activity of luciferase (bioluminescent intensity).

[0129] Materials and Methods:

[0130] Cell seeding of BC cells

[0131] Aspirate the medium on the MELN cells (see Table 1)

[0132] Wash once with PBS, then aspirate the PBS

[0133] Add trypsin on cells, aspirate excess trypsin

[0134] Incubate at 37°C for 5 minutes

[0135] Repeatedly pipette leukocyte medium (DMEM without phenol red 10% charcoal-treated fetal calf serum) onto the cells to dissociate, then collect them into tubes

[0136] Cells were seeded at 10,000 ...

Embodiment 2

[0175] describe:

[0176] Encapsulated BC cells stably expressing the dual reporter gene FUCCI (see Table 2) in far-red-labeled cysts and encapsulated LC cells stably expressing the dual reporter gene FUCCI in unlabeled cysts were incubated at different serum concentrations co-cultivation. The number of actively proliferating and non-proliferating cells (latency) was determined by simultaneously quantifying the ratio of red (G1 phase) and green (G2 / S phase) nuclei in LC cells and BC cells in the same co-culture well.

[0177] Materials and Methods:

[0178] Protocol for establishing a stable reporter cell line:

[0179] HEK293 cells were seeded in 10 cm dishes at 4 million cells / dish.

[0180] Incubate at 37°C for 24 hours.

[0181] Cells were transfected with a mixture of plasmids pMD2G, psPAX2, and a lentiviral reporter plasmid of interest (pBOB-EF1-fastFUCCI-puro) by using the polyethylenimine transfection method.

[0182] The transfection solution was added to the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a multiplexed and encapsulated 3D cell co-culture drug testing or screening method. Also disclosed are in vitro drug test kits suitable for testing the impact of one or more drugs of interest on a variety of biological processes in one or more target cell types.

Description

technical field [0001] The present invention relates to a multiplexed and encapsulated 3D cell co-culture drug testing or screening method. The present invention also discloses an in vitro drug testing kit, which is suitable for testing the effects of one or more target drugs on various biological processes in one or more target cell types. Background technique [0002] In vitro screening or testing of molecular entities on biological cells constitutes a fundamental procedure for the discovery of new drugs and more recently in "precision medicine" testing to determine the best drug or drugs to treat a patient. In vitro molecular screening can be used in the early stages of drug discovery to identify "hit" molecules, or at a later stage to define from these hit molecules a set of "lead" entities, which are defined as hits with a variety of favorable characteristics entity. In vitro drug testing can be very expensive in terms of time and resources due to the large number of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/02C12Q1/18G01N21/64G01N21/76
CPCG01N33/5008G01N21/6428G01N21/763G01N2500/10G01N2021/6439G01N33/5011G01N33/5014G01N33/5041G01N33/5044G01N33/5067C12Q1/18C12Q1/025C12M25/16C12Q1/6897C12Q2563/159C12Q2563/103C12Q2563/107C12Q1/66
Inventor 格雷戈里·塞加拉大卫·佩约斯基奥雷利安·鲁克斯迪迪埃·皮卡德迪米特里·文森特·莫罗布莱恩·约书亚·博拉特
Owner UNIVERSITY OF GENEVA